| Molecule Linked With Advanced Prostate Cancer
Many men end up having prostate biopsies when there's no cancer present. And because of an elevated PSA level, some men may be diagnosed with a prostate cancer that they would have never even known about otherwise and would never have caused any symptoms. If results from the current study are validated by additional studies and a test is developed, many men could potentially avoid unnecessary treatment that often compromises quality-of-life. "We could potentially monitor the metabolites in a prostate cancer sample to tell us which patients have the more aggressive disease that will progress on to metastasis," says Chinnaiyan. "We also believe that the findings may have therapeutic implications because one of the interesting findings in this particular study is that pathways that are involved in sarcosine metabolism appear to be involved in cancer invasiveness and prostate cancer aggressiveness in general." "This could be a wonderful find, if it holds up," says Durado Brooks, MD, director of prostate and colorectal cancers at the American Cancer Society.
Still waiting for cancer care
��We�re confident that he will also move ahead with the rapid-access clinics for prostate cancer and lung cancer within the coming 18 months.�
Plans to expand radiation therapy services around the country are also continuing, but it is unclear how the economic recession will affect the rollout of these expensive and labour-intensive services. Within the next week or two, the Health Service Executive hopes to �go live� with the new hospital consultants� contract, which will involve hospital doctors in multidisciplinary teams and clinical audits.
At a press briefing on the implementation of recommendations of the Commission on Public Safety last Thursday, Harney predicted that, alongside the reconfiguration of hospital services, a new era of patient safety and accountability was beginning.
National briefs
America" on Monday that he donated sperm to Suleman during their three-year relationship in the late 1990s because she claimed to have ovarian cancer. Suleman denied Beaudoin was the donor she used to conceive her children, ABC said. When pressed, she admitted he had donated sperm to her but he was unable to have children, the network said. Beaudoin is divorced and has two children from the marriage. Beaudoin still wants DNA testing. He said he was misled about why she needed him to make three sperm donations "because she couldn't have kids and, you know, it turned into this." Snow knocks out power, shuts schools PORTLAND, Maine -- A winter storm blew through northern New England on Monday, dumping 2 feet of snow in spots, forcing hundreds of schools to cancel classes and leaving tens of thousands of homes and businesses without power.
Clark Howard’s diagnosis highlights prostate cancer
Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. > The American Cancer Society estimates that 28,660 men in the United States died of prostate cancer in 2008. > Prostate cancer accounts for about 10 percent of cancer-related deaths in men. Source: American Cancer Society Questions to ask if you've been diagnosed: > What are the chances that the cancer has spread beyond my prostate? If so, is it still curable? > What further tests, if any, do you recommend, and why? > What is the clinical stage and Gleason score, or grade, of my cancer? What do those mean in my case? > What is my expected survival rate based on clinical stage, grade and various treatment options? > Should I consider watchful waiting as an option? Why or why not? > Do you recommend a radical prostatectomy or radiation? Why or why not? > If you recommend radical prostatectomy, will it be nerve sparing? > Should I consider laparoscopic or robot-assisted prostatectomy? > What types of radiation therapy might work best for me? > What other treatments might be right for me? Why? > Among those treatments, what are the risks or side effects that I should expect? > What are the chances that I will have problems with incontinence or impotence? > What are the chances that I will have other urinary or rectal problems? > What are the chances of recurrence of my cancer with the treatment programs we have discussed? What would be our next step if this happened? > Should I follow a special diet? Source: American Cancer Society .
CyberKnife For Prostate Cancer -- Research Summary
BACKGROUND: Prostate cancer will hit one in six men in his lifetime, according to the Prostate Cancer Foundation. This makes it the most common non-skin cancer in the United States. To survive the disease, it's important to catch it early. The American Cancer Society recommends men age 50 or older undergo both a PSA blood test, which checks levels of a protein produced by the prostate, and digital rectal exams every year. Men at high risk should start being tested at age 45. In addition to receiving annual screenings, men should watch out for symptoms that include the following: a need to urinate frequently, difficulty starting or holding back urination, blood in urine and frequent pain or stiffness in the lower back, hips or upper thighs. TREATMENT: Treatment of prostate cancer differs depending on the stage the cancer is found in, but the traditional course involves surgery and radiation therapy.
Stewkley music festival given the go-ahead
It will be a ticket-only fundraising event in aid of the Breast Cancer Appeal. People will be able to camp overnight or come for one day.What do you think of this story?To comment on this or any other Bucks Herald story, click here.To post comments directly on this website, click on the Comment on this Story link below .
Potential skin cancer treatment tested on tadpoles
The scientists think inhibiting the cells' movement can avert skin cancer metastasis in both frogs and humans. The chemical should be tested in other species and could someday be used to develop drugs to treat skin cancer in people, the study's lead author said. Financial Times (01/30) Doctors warn Tysabri may increase melanoma danger Thursday, February 7, 2008 Tumors can originate from one cancer cell, researchers say Thursday, December 4, 2008 Dendreon's midtrial data on Provenge expected in October Wednesday, August 13, 2008 Related News Stories Related Press Releases Computer screen 'tan' tricks thousands BBC | Friday, February 6, 2009 Tadpoles could help develop skin cancer drugs Boston Globe, The | Friday, January 30, 2009 Skin Color Studies On Tadpoles Lead To Cancer Advance Science Daily Magazine | Saturday, January 31, 2009 Tadpoles offer skin cancer hope Financial Times | Thursday, January 29, 2009 Tadpoles may hold cancer clue BBC | Friday, January 30, 2009 .
Conventional Cancer Treatment Linked to Bone Loss
(NaturalNews) The adverse health effects of conventional cancer treatment are numerous, and some well-known ones include hair loss, loss of appetite, nausea, constipation and even organ failure. A recent study carried out in Canada has revealed that treatments for breast cancer and prostate cancer can cause bone loss, too.
Details and Findings of Study
Published online in the Journal of Clinical Oncology, the study was led by Dr Fred Saad, who is the director of urologic oncology at the Universite de Montreal's Faculty of Medicine and the Centre Hospitalier de l'Universite de Montreal (CHUM), and its team included members from McMaster University, the Universite Laval, the University of British Columbia, as well as the University of Toronto.
All in all, the research team looked at and analyzed data from a staggering number of previous studies on breast cancer and prostate cancer - more than 3,500 of them.
Growth can be so slow that surgery or radiation are not
Carter looked at Bentey's blood work and did his own biopsy. The doctor's conclusion? Bentey had prostate cancer, but the New Jersey man did not need surgery. At least not right away.
Bentey's cancer appeared to be growing slowly, so Carter recommended a wait-and-see approach.
"He said, 'You're going to die someday, but I don't think it's going to be of prostate cancer,'" Bentey recalls.
.
Adjuvant Radiotherapy Useful for PT3 N0M0 Prostate Cancer
Prior research has shown that roughly a third of men who undergo radical prostatectomy for apparently localized prostate cancer will develop extraprostatic disease. Whether adjuvant radiotherapy may help cut risk of metastatic disease and mortality was unclear. Dr. Ian M. Thompson, from the University of Texas Health Science Center, San Antonio, and colleagues addressed this topic by assessing the outcomes of 431 men who were randomized to receive adjuvant radiotherapy (60 to 64 Gy) or observation after radical prostatectomy. Seventy of the 211 men randomized to observation later received radiotherapy. Radiotherapy increased the odds of metastasis-free survival and overall survival. Specifically, the hazard ratio for metastasis in the radiotherapy arm versus the observation arm was 0.71 (p = 0.016), and the corresponding mortality hazard ratio was 0.72 (p = 0.023).
|
